| Earning the FDA's prized Breakthrough Therapy designation is just the beginning of the race, one that likely requires use of an imaging surrogate for preclinical evidence and accelerated approval.
In these instances, imaging must be performed correctly, and results delivered quickly. Data can be required by the agency in less than one month. Will you be ready to respond?
Get an insider's view of what happens when the stakes, scrutiny, and demands of clinical trial imaging are sky-high. Read the complimentary white paper, "Behind the Breakthrough," and learn how to get medical imaging done right in your Breakthrough Therapy trial.
|
